Pharmaceutical News

RSS

Sinovac Biotech to distribute PANFLU.1 vaccine in Mexico

Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading developer and provider of vaccines in China, today announced that it has received a Certificate of Approval from the Secretaria de Salud to distribute PANFLU.1, its H1N1 pandemic influenza (swine flu) vaccine, in Mexico. The certificate is valid through October 13, 2014.

23 Oct 2009

Antidepressant prescriptions are on the rise

A dramatic rise in antidepressant prescriptions issued by GPs has been caused by a year on year increase in the number of people taking antidepressant drugs on a long-term basis, according to researchers from the University of Southampton.

23 Oct 2009

Study: General anesthesia can cause brain injury in immature rats

Studies by researchers at Wake Forest University School of Medicine have shown that blocking the NMDA receptor in immature rats leads to profound, rapid brain injury and disruption of auditory function as the animals mature.

23 Oct 2009

Study reveals benefits of recombinant human C1 inhibitor in treating ischemic brain injury

Biotech company Pharming Group NV announced today publication of a preclinical study showing the benefit of using recombinant human C1 inhibitor (rhC1INH) in ischemic brain injury.

23 Oct 2009

Relationship between cannabis and schizophrenia is controversial

Last year the UK government reclassified cannabis from a class C to a class B drug, partly out of concerns that cannabis, especially the more potent varieties, may increase the risk of schizophrenia in young people. But the evidence for the relationship between cannabis and schizophrenia or psychosis remains controversial.

23 Oct 2009

MedImmune announces interim data from its live attenuated influenza vaccine studies

MedImmune announced today that interim data from human studies of its nasal spray vaccine for the 2009 novel Influenza A (H1N1) virus demonstrate a similar clinical profile in children and adults 2 to 49 years of age as previously studied seasonal formulations of the vaccine.

23 Oct 2009

Pfizer-Wyeth merger analyzed

Drug companies are carefully navigating the current stretch of industry consolidation as giants merge and promising small firms seek interested buyers.

23 Oct 2009

AEOL 10150 increases regeneration of GI stem cells: NIAID study results

Aeolus Pharmaceuticals, Inc. announced today that recent experiments in preclinical models conducted by the National Institutes of Health’s (NIH), National Institute of Allergy and Infectious Diseases (NIAID) Radiation/Nuclear Medical Countermeasure Development program have shown that AEOL 10150 can effectively increase regeneration of gastro-intestinal (GI) stem cells, reduce the severity and duration of diarrhea and improve survival when administered at 24 hours after doses of total-body irradiation that produce the lethal GI syndrome.

23 Oct 2009

Combination treatement for IVF patients may eliminate vaginal bleeding

A prospective, multi-center study demonstrated that in IVF (in vitro fertilization) cycles supplemented with once-daily dosing of Crinone® vaginal progesterone gel and Estrace® oral estrogen, vaginal bleeding is rare in patients who become pregnant. Bleeding does occur in approximately one-quarter of patients who do not become pregnant. These data were presented at the American Society for Reproductive Medicine (ASRM) annual meeting in Atlanta.

23 Oct 2009

In vitro activity results of Cem-101 against gram-positive organisms to be presented

Cempra Pharmaceuticals today announced its schedule of oral and poster presentations at the Infectious Disease Society of America, 47th Annual Meeting, in Philadelphia on Oct. 29 to Nov. 1, 2009.

23 Oct 2009

Canadian Cardiovascular Society to honor University of Alberta medical researcher

A University of Alberta medical researcher being hailed as a world leader in his field will receive a major national award for his pioneering work in the development of a new class of drugs for the treatment of heart failure.

23 Oct 2009

Liraglutide drug causes less nausea and hypoglycaemia compared to exenatide

New data on patient treatment satisfaction from the LEAD(TM) 6 trial presented on the 22nd October at the 20th World Diabetes Congress (International Diabetes Federation) shows that patients have higher overall treatment satisfaction with liraglutide than they do with exenatide.

23 Oct 2009

CellAura to provide pharmacologically validated reagents for Cisbio Bioassays' cellular studies

CellAura, the leading producer of fluorescence reagents for drug discovery and life sciences research, today announced a development partnership with Cisbio Bioassays. Under the terms of the agreement, CellAura will provide pharmacologically validated reagents to Cisbio Bioassays that will be applied to Cisbio Bioassays’ Tag-lite™ range of non-radioactive assays for cellular studies.

23 Oct 2009

Theravance earns milestone payment for bactericidal, injectable lipoglycopeptide antibiotic

Theravance, Inc. announced today that it has earned a milestone payment of $20 million for the U.S. Food and Drug Administration (FDA) approval of VIBATIV (telavancin) and supplying its collaboration partner, Astellas Pharma US, Inc. (Astellas), with the launch inventory for the first commercial sale in the United States.

23 Oct 2009

Adjuvanted and non-adjuvanted H1N1 vaccines safe for pregnant women, say Canadian experts

After discussion with the Public Health Agency of Canada, and based on the evidence for other adjuvanted vaccines as well as experience around the world to date with the adjuvanted H1N1 vaccine, Canadian experts say that both the adjuvanted and non-adjuvanted H1N1 vaccines are safe for pregnant women.

23 Oct 2009

XenaCare Holdings to advertise OTC pain reliever in NASCAR’s annual publication

XenaCare Holdings, Inc. (OTCBB: XCHO), a company specializing in the marketing and retail distribution of consumer healthcare products, has announced today that it has signed an agreement to market its over-the-counter (OTC) pain reliever, Cobroxin, in Racing One, the official annual publication of NASCAR, for the 2010 racing season.

23 Oct 2009

Majority of allergy patients can be vaccinated against swine flu after evaluation by an allergist

Once supply catches up with the immediate demand for H1N1 "swine" flu vaccine, some allergy patients who could benefit from the vaccine may needlessly avoid it due to confusion over who should, and should not, be vaccinated, cautions Dr. Peter R. Smith, a board-certified allergist and clinical immunologist with Allergy Partners of Fredericksburg, Virginia.

23 Oct 2009

Affymax to make multiple presentations on preclinical and clinical data of Hematide

Affymax, Inc. today announced multiple presentations at the American Society of Nephrology (ASN) Renal Week 2009 taking place October 27 through November 1 in San Diego.

23 Oct 2009

45% of American adults not inclined to get vaccinated against seasonal flu

Two in five at-risk American adults who would benefit from vaccination against seasonal flu are missing out on the protective shots because they believe they do not need them and are not inclined to be vaccinated. And among those who say they do intend to take up the vaccine, nearly half get around to it, according to Dr. Katharine Harris from the RAND Corporation in Arlington, USA, and her team.

23 Oct 2009

AFP examines recent HIV vaccine findings

Agence France-Presse examines how two recent studies have "boosted morale" among HIV vaccine researchers who have struggled for decades to develop a viable vaccine to protect people from the virus. "On September 3, researchers in the United States discovered two potent antibodies -- the frontline troops in the immune system -- that expose what may prove to be a viral Achilles' heel," the news service writes.

22 Oct 2009

Pharmaceutical News

Sinovac Biotech to distribute PANFLU.1 vaccine in Mexico

Antidepressant prescriptions are on the rise

Study: General anesthesia can cause brain injury in immature rats

Study reveals benefits of recombinant human C1 inhibitor in treating ischemic brain injury

Relationship between cannabis and schizophrenia is controversial

MedImmune announces interim data from its live attenuated influenza vaccine studies

Pfizer-Wyeth merger analyzed

AEOL 10150 increases regeneration of GI stem cells: NIAID study results

Combination treatement for IVF patients may eliminate vaginal bleeding

In vitro activity results of Cem-101 against gram-positive organisms to be presented

Canadian Cardiovascular Society to honor University of Alberta medical researcher

Liraglutide drug causes less nausea and hypoglycaemia compared to exenatide

CellAura to provide pharmacologically validated reagents for Cisbio Bioassays' cellular studies

Theravance earns milestone payment for bactericidal, injectable lipoglycopeptide antibiotic

Adjuvanted and non-adjuvanted H1N1 vaccines safe for pregnant women, say Canadian experts

XenaCare Holdings to advertise OTC pain reliever in NASCAR’s annual publication

Majority of allergy patients can be vaccinated against swine flu after evaluation by an allergist

Affymax to make multiple presentations on preclinical and clinical data of Hematide

45% of American adults not inclined to get vaccinated against seasonal flu

AFP examines recent HIV vaccine findings

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News